An Unusual Case of Primary Mucocutaneous Cytotoxic T-Cell Lymphoma With Epidermotropism and Phenotype Switch: Diagnostic and Molecular Insights.
1/5 보강
Primary cutaneous aggressive epidermotropic CD8 cytotoxic T-cell lymphoma (PCAECTCL) is a rare, rapidly progressive cutaneous T-cell lymphoma that poses significant diagnostic challenges, particularly
APA
Singh AP, Obiorah IE (2026). An Unusual Case of Primary Mucocutaneous Cytotoxic T-Cell Lymphoma With Epidermotropism and Phenotype Switch: Diagnostic and Molecular Insights.. Journal of cutaneous pathology, 53(3), 263-269. https://doi.org/10.1111/cup.70035
MLA
Singh AP, et al.. "An Unusual Case of Primary Mucocutaneous Cytotoxic T-Cell Lymphoma With Epidermotropism and Phenotype Switch: Diagnostic and Molecular Insights.." Journal of cutaneous pathology, vol. 53, no. 3, 2026, pp. 263-269.
PMID
41371249 ↗
Abstract 한글 요약
Primary cutaneous aggressive epidermotropic CD8 cytotoxic T-cell lymphoma (PCAECTCL) is a rare, rapidly progressive cutaneous T-cell lymphoma that poses significant diagnostic challenges, particularly in mucocutaneous variants. We report a case in a 49-year-old man who presented with upper lip swelling initially misdiagnosed as angioedema and cheilitis granulomatosa. A lip biopsy revealed atypical CD4/CD8 double-negative T cells with marked epidermotropism, initially interpreted as pagetoid mycosis fungoides. Subsequent immunophenotyping demonstrated a cytotoxic profile (CD3, CD2, CD7, CD5, CD4, CD8, CD20, perforin, granzyme B, TCRBF1, CD56, and TCRδ). Imaging later identified tongue involvement with a similar phenotype, though CD8 expression was weak and CD20 expression was absent. The disease progressed to lymph nodes, oropharynx, and stomach, with an eventual phenotypic switch to CD8. Molecular testing confirmed similar clonal T-cell rearrangements across all sites. Sequencing identified JAK3 and TP53 mutations, while chromosomal microarray revealed recurrent losses (1p, 2q, 3p, 4p, 11q, 13q, and 17q) and gains (7q, 17p), without JAK2 fusion. Despite aggressive therapy, the patient died 21 months after diagnosis. This case delineates the importance of early biopsy, integration of molecular studies, and the urgent need for therapies to improve outcomes in this aggressive lymphoma.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.